Two recent federal criminal actions show the Justice Department continuing to press aggressively in both competition and health care enforcement. In Oklahoma City, a federal jury convicted Sioux Erosion Control Inc., along with one executive and one employee, for participating in a roughly $100 million bid-rigging and price-fixing conspiracy tied to public transportation contracts. In a separate matter, prosecutors unsealed a racketeering indictment accusing four alleged members of the “War Room” of orchestrating a $12 million Medicaid fraud scheme.

Taken together, the matters are a reminder that DOJ is treating criminal antitrust and health care fraud as parallel priority areas, with consequences that extend well beyond the charged defendants.

The Federal Trade Commission has weighed in behind a proposal before the Ohio Supreme Court that would reduce the American Bar Association’s central role in determining which law schools qualify graduates for bar admission. While the change is specific to Ohio’s attorney-licensing framework, the implications are much broader: it touches the long-running debate over whether a single private organization should wield outsized influence over entry into the legal profession.

For decades, ABA accreditation has functioned as the default gatekeeper for many state bar systems.

The FTC has secured what it says is the largest civil penalty ever obtained for a Hart-Scott-Rodino filing failure: a combined $12 million settlement with Edwards Lifesciences and Genesis MedTech over the acquisition of JC Medical. According to the agency, the companies structured the transaction to avoid premerger notification and waiting-period requirements under the HSR Act, prompting an enforcement action filed in the U.S. District Court for the District of Columbia by the DOJ on the FTC’s behalf.

That headline number matters.

The Federal Trade Commission has announced what it calls a major antitrust settlement with Caremark, resolving a closely watched case against one of the country’s largest pharmacy benefit managers. Even without the full settlement details in hand, the development is important: it signals that the FTC is continuing to press competition theories aimed at the role PBMs play in drug pricing, formulary design, and pharmacy reimbursement.

For antitrust and healthcare lawyers, the significance goes well beyond a single company.

The Federal Trade Commission has inserted itself into a debate with potentially long-term consequences for the legal profession: who gets to decide whether a lawyer’s education is good enough for bar admission. In a recent endorsement of an Ohio Supreme Court proposal, the FTC supported reducing the American Bar Association’s outsized role in determining whether a law school credential qualifies an applicant to sit for the bar.

That is more than an academic governance issue.

The U.S. Department of Justice Antitrust Division has announced that it is resuming a more targeted Hart-Scott-Rodino merger review process, an important procedural shift for companies navigating premerger notification in 2026. Although this is not a court filing or enforcement complaint, it is still a meaningful legal development: it tells dealmakers and their counsel how one of the government’s primary antitrust enforcers intends to allocate resources and frame early-stage merger scrutiny.

At a practical level, a “targeted” review approach suggests the Division is moving away from a broader, more expansive initial review posture and returning to a process more closely tailored to transactions that present identifiable competitive risks.

The Justice Department’s proposed settlement with Willow Bridge Property Company LLC marks another important step in the government’s expanding antitrust challenge to rent-setting tools and shared market data in multifamily housing. The case, filed in the U.S. District Court for the Middle District of North Carolina, fits into a broader enforcement push targeting allegations that landlords used common pricing software and competitively sensitive information to coordinate rents.

While the specific terms of the proposed resolution will matter, the headline takeaway is already clear: DOJ is not treating rental algorithms as a niche issue.

The Justice Department’s Antitrust Division has resumed a targeted Hart-Scott-Rodino review process, an important signal that federal merger scrutiny remains active and potentially more exacting for certain transactions. While this development is not tied to a single headline-grabbing court fight, it matters because the HSR process is the front door to U.S. merger enforcement: changes in how the government screens deals can directly affect closing timelines, regulatory strategy, and overall transaction risk.

The announcement from the U.S. Department of Justice Antitrust Division suggests that parties should expect renewed attention to selected reportable deals during the premerger review stage.

The Justice Department has proposed an antitrust settlement with Willow Bridge Property Company LLC, one of the country’s largest landlords, in a case that underscores a continuing enforcement priority: the use of pricing algorithms and shared competitively sensitive information in rental housing markets.

According to the government, the case centers on allegations that Willow Bridge participated in information sharing and coordination practices affecting apartment rents.

A California-led coalition of 12 states has filed a federal antitrust suit in the Northern District of California seeking to block Paramount’s proposed $110 billion deal involving Warner Bros.

The FTC has announced a significant settlement with Caremark Rx LLC and Zinc Health Services LLC in its insulin-pricing antitrust matter, marking one of the clearest signals yet that pharmacy benefit manager rebate structures remain a top enforcement priority. According to the agency, the deal is designed to reduce patients’ out-of-pocket costs, increase transparency, and curb rebate practices that allegedly contributed to higher insulin list prices.

The proceeding, Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin), is part of the FTC’s broader challenge to how major drug middlemen negotiate formularies, rebates, and placement decisions for high-demand medications.

The Justice Department has announced a proposed antitrust settlement with Willow Bridge, one of the country’s largest landlords, resolving allegations that the company participated in unlawful information-sharing and algorithmic coordination in apartment pricing. While the matter is not a private damages case, it is an important marker in the government’s broader campaign against rent-setting practices that allegedly reduce competition in local housing markets.

The significance of the settlement goes beyond a single landlord.

The Justice Department’s proposed settlement with Willow Bridge Property Company marks another meaningful step in the government’s campaign against alleged algorithmic coordination in rental housing. The case, brought by the Antitrust Division in the Middle District of North Carolina, focuses on whether landlords’ sharing of competitively sensitive information and use of pricing software crossed the line from lawful revenue management into unlawful coordination.

Although the proposed resolution applies specifically to Willow Bridge, its significance is broader.

The Justice Department’s proposed antitrust settlement with Willow Bridge, announced July 6, 2026, is the latest indication that federal enforcers remain focused on alleged coordination in multifamily housing markets — particularly where information sharing and pricing technology intersect.

A federal judge in New York has granted preliminary approval to a revised $38 billion settlement in the long-running interchange-fee litigation against Visa and Mastercard, marking another major milestone in one of the largest antitrust-related civil cases in U.S. history. The case centers on merchant allegations that the card networks and related defendants imposed excessive “swipe fees” and maintained anticompetitive rules that inflated the cost of accepting credit cards.

Preliminary approval is not the end of the road.